BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36707610)

  • 1. LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma.
    Sato S; Gillette M; de Santiago PR; Kuhn E; Burgess M; Doucette K; Feng Y; Mendez-Dorantes C; Ippoliti PJ; Hobday S; Mitchell MA; Doberstein K; Gysler SM; Hirsch MS; Schwartz L; Birrer MJ; Skates SJ; Burns KH; Carr SA; Drapkin R
    Sci Rep; 2023 Jan; 13(1):1537. PubMed ID: 36707610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker.
    Taylor MS; Wu C; Fridy PC; Zhang SJ; Senussi Y; Wolters JC; Cajuso T; Cheng WC; Heaps JD; Miller BD; Mori K; Cohen L; Jiang H; Molloy KR; Chait BT; Goggins MG; Bhan I; Franses JW; Yang X; Taplin ME; Wang X; Christiani DC; Johnson BE; Meyerson M; Uppaluri R; Egloff AM; Denault EN; Spring LM; Wang TL; Shih IM; Fairman JE; Jung E; Arora KS; Yilmaz OH; Cohen S; Sharova T; Chi G; Norden BL; Song Y; Nieman LT; Pappas L; Parikh AR; Strickland MR; Corcoran RB; Mustelin T; Eng G; Yilmaz ÖH; Matulonis UA; Chan AT; Skates SJ; Rueda BR; Drapkin R; Klempner SJ; Deshpande V; Ting DT; Rout MP; LaCava J; Walt DR; Burns KH
    Cancer Discov; 2023 Dec; 13(12):2532-2547. PubMed ID: 37698949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
    Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
    J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 5. Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multi-cancer biomarker.
    Taylor MS; Connie W; Fridy PC; Zhang SJ; Senussi Y; Wolters JC; Cheng WC; Heaps J; Miller BD; Mori K; Cohen L; Jiang H; Molloy KR; Norden BL; Chait BT; Goggins M; Bhan I; Franses JW; Yang X; Taplin ME; Wang X; Christiani DC; Johnson BE; Meyerson M; Uppaluri R; Egloff AM; Denault EN; Spring LM; Wang TL; Shih IM; Jung E; Arora KS; Zukerberg LR; Yilmaz OH; Chi G; Matulonis UA; Song Y; Nieman L; Parikh AR; Strickland M; Corcoran RB; Mustelin T; Eng G; Yilmaz ÃH; Skates SJ; Rueda BR; Drapkin R; Klempner SJ; Deshpande V; Ting DT; Rout MP; LaCava J; Walt DR; Burns KH
    bioRxiv; 2023 Mar; ():. PubMed ID: 36747644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Role of Fallopian Ciliated Cells in the Pathogenesis of High-Grade Serous Ovarian Cancer.
    Coan M; Rampioni Vinciguerra GL; Cesaratto L; Gardenal E; Bianchet R; Dassi E; Vecchione A; Baldassarre G; Spizzo R; Nicoloso MS
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
    Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
    BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray.
    Wang S; Yin C; Zhang Y; Zhang L; Tao L; Liang W; Pang L; Fu R; Ding Y; Li F; Jia W
    Biomed Res Int; 2019; 2019():2867372. PubMed ID: 31312656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling high-grade serous ovarian carcinogenesis from the fallopian tube.
    Karst AM; Levanon K; Drapkin R
    Proc Natl Acad Sci U S A; 2011 May; 108(18):7547-52. PubMed ID: 21502498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal Proliferations in Completely Examined Fallopian Tubes Accompanying Ovarian Low-grade Serous Tumors: Neoplastic Precursor Lesions or Normal Variants of Benign Mucosa?
    Wolsky RJ; Price MA; Zaloudek CJ; Rabban JT
    Int J Gynecol Pathol; 2018 May; 37(3):262-274. PubMed ID: 28700429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development.
    Sherman-Baust CA; Kuhn E; Valle BL; Shih IeM; Kurman RJ; Wang TL; Amano T; Ko MS; Miyoshi I; Araki Y; Lehrmann E; Zhang Y; Becker KG; Morin PJ
    J Pathol; 2014 Jul; 233(3):228-37. PubMed ID: 24652535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer.
    Wu H; Li R; Zhang Z; Jiang H; Ma H; Yuan C; Sun C; Li Y; Kong B
    J Ovarian Res; 2019 Dec; 12(1):125. PubMed ID: 31884974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Interspersed Nuclear Element 1 Retrotransposons Become Deregulated during the Development of Ovarian Cancer Precursor Lesions.
    Pisanic TR; Asaka S; Lin SF; Yen TT; Sun H; Bahadirli-Talbott A; Wang TH; Burns KH; Wang TL; Shih IM
    Am J Pathol; 2019 Mar; 189(3):513-520. PubMed ID: 30553834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciliated Cells in Ovarian Cancer Decrease with Increasing Tumor Grade and Disease Progression.
    Richardson MT; Recouvreux MS; Karlan BY; Walts AE; Orsulic S
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High grade serous ovarian carcinomas originate in the fallopian tube.
    Labidi-Galy SI; Papp E; Hallberg D; Niknafs N; Adleff V; Noe M; Bhattacharya R; Novak M; Jones S; Phallen J; Hruban CA; Hirsch MS; Lin DI; Schwartz L; Maire CL; Tille JC; Bowden M; Ayhan A; Wood LD; Scharpf RB; Kurman R; Wang TL; Shih IM; Karchin R; Drapkin R; Velculescu VE
    Nat Commun; 2017 Oct; 8(1):1093. PubMed ID: 29061967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expansion of secretory cells in the fallopian tubal epithelium in the early stages of the pathogenesis of ovarian serous carcinomas].
    Asaturova AV; Ezhova LS; Faizullina NM; Adamyan LV; Khabas GN; Sannikova MV
    Arkh Patol; 2017; 79(3):10-18. PubMed ID: 28631711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.
    Vang R; Shih IeM; Kurman RJ
    Histopathology; 2013 Jan; 62(1):44-58. PubMed ID: 23240669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locus-specific LINE-1 expression in clinical ovarian cancer specimens at the single-cell level.
    Perkiö A; Pradhan B; Genc F; Pirttikoski A; Pikkusaari S; Erkan EP; Falco MM; Huhtinen K; Narva S; Hynninen J; Kauppi L; Vähärautio A
    Sci Rep; 2024 Feb; 14(1):4322. PubMed ID: 38383551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global miRNA/proteomic analyses identify miRNAs at 14q32 and 3p21, which contribute to features of chronic iron-exposed fallopian tube epithelial cells.
    Chhabra R; Rockfield S; Guergues J; Nadeau OW; Hill R; Stevens SM; Nanjundan M
    Sci Rep; 2021 Mar; 11(1):6270. PubMed ID: 33737539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-grade serous ovarian cancer arises from fallopian tube in a mouse model.
    Kim J; Coffey DM; Creighton CJ; Yu Z; Hawkins SM; Matzuk MM
    Proc Natl Acad Sci U S A; 2012 Mar; 109(10):3921-6. PubMed ID: 22331912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.